Exhibit 99

 image01.jpg

RCM Technologies, Inc.

Tel: 856.356.4500

Corporate Contacts:

2500 McClellan Avenue

info@rcmt.com

Bradley S. Vizi

Pennsauken, NJ 08109

www.rcmt.com

Executive Chairman

 

 

Kevin D. Miller

   

Chief Financial Officer

 

 

P R E S S   R E L E A S E

 

RCM TECHNOLOGIES, INC. ANNOUNCES

FIRST QUARTER RESULTS

 

Pennsauken, NJ – May 7, 2025 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen weeks ended March 29, 2025.

 

RCM Technologies reported revenue of $84.5 million for the thirteen weeks ended March 29, 2025 (the current quarter), an increase of 17.4% compared to $71.9 million for the thirteen weeks ended March 30, 2024 (the comparable prior quarter). Gross profit was $22.0 million for the current quarter, a 7.9% increase compared to $20.4 million for the comparable prior quarter.  The Company experienced GAAP net income of $4.2 million, or $0.54 per diluted share, for the current quarter compared to $4.0 million, or $0.48 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $7.8 million for the current quarter, as compared to $6.8 million for the comparable prior quarter.  The Company experienced $0.63 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.53 for the comparable prior quarter.

 

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “The internals of our business continue to strengthen at an increasing rate. We believe the company is well positioned based on the thoughtful investment strategy we have deployed, and significant reductions in our share count should enhance the compounding of returns to the benefit of shareholders.”

 

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “We are very pleased with our cash flow this quarter, as we generated $16.7 million in cash flow from operations and reduced our net debt by $12.0 million while retiring shares and growing earnings at a healthy clip.”

 

 

 

 

Conference Call

On Thursday, May 8, 2025, RCM Technologies will host a conference call to discuss these results. The call will begin at 10:30 a.m. Eastern Time. The dial-in number is (888) 272-8703.

 

About RCM

RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

 

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

 

Tables to Follow

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Share and Per Share Amounts)

 

 

 

Thirteen Weeks Ended

 
 

March 29,

2025

 

March 30,

2024

 

Revenue

$84,473

 

$71,939

 

Cost of services

62,495

 

51,572

 

Gross profit

21,978

 

20,367

 

Selling, general and administrative

14,971

 

14,199

 

Depreciation and amortization of property and equipment

424

 

287

 

Amortization of acquired intangible assets

-

 

45

 

Operating income

6,583

 

5,836

 

Other expense, net

698

 

426

 

Income before income taxes

5,885

 

5,410

 

Income tax expense

1,699

 

1,458

 

Net income

$4,186

 

$3,952

 
         

Diluted net earnings per share data

$0.54

 

$0.48

 

Diluted weighted average shares outstanding

7,741,481

 

8,170,839

 

 

 

 

 

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA,” “Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance.  In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

 

The following unaudited table presents the Company’s GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen weeks ended March 29, 2025 and March 30, 2024.   

 

 

Thirteen Weeks Ended

 
 

March 29,

2025

 

March 30,

2024

 
 

(Unaudited)

     
         

GAAP operating income

$6,583

 

$5,836

 

Adjustments

       

Equity compensation

773

 

635

 

Adjusted operating income (non-GAAP)

$7,356

 

$6,471

 
         

GAAP net income

$4,186

 

$3,952

 

Income tax expense

1,699

 

1,458

 

Interest expense, net

651

 

478

 

Depreciation of property and equipment

424

 

287

 

Amortization of acquired intangible assets

-

 

45

 

EBITDA (non-GAAP)

$6,960

 

$6,220

 
         

Adjustments

       

Loss (gain) on foreign currency transactions

47

 

(52

)

Equity compensation

773

 

635

 

Adjusted EBITDA (non-GAAP)

$7,780

 

$6,803

 

 

 

 

 

 

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis (Continued)

(Unaudited)

(In Thousands)

 

 

 

Thirteen Weeks Ended

 
 

March 29,

2025

 

March 30,

2024

 
 

(Unaudited)

     
         

GAAP net income

$4,186

 

$3,952

 

Adjustments

       

Loss (gain) on foreign currency transactions

47

 

(52

)

Equity compensation

773

 

635

 

Tax impact from normalized rate

(111

)

(160

)

Adjusted net income (non-GAAP)

$4,895

 

$4,375

 
         

GAAP diluted net earnings per share

$0.54

 

$0.48

 

Adjustments

       

Loss (gain) on foreign currency transactions

0.01

 

(0.01

)

Equity compensation

0.10

 

0.08

 

Tax impact from normalized rate

(0.02

)

(0.02

)

Adjusted diluted net earnings per share (non-GAAP)

$0.63

 

$0.53

 

 

 

 

 

RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

 

 

 

 

Thirteen Weeks Ended March 29, 2025

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences,

Data and

Solutions

 

Consolidated

 
                 

Revenue

$43,283

 

$32,142

 

$9,048

 

$84,473

 

Cost of services

31,080

 

25,957

 

5,458

 

62,495

 

Gross profit

$12,203

 

$6,185

 

$3,590

 

$21,978

 

Gross profit margin

28.2

%

19.2

%

39.7

%

26.0

%

 

 

 

 

Thirteen Weeks Ended March 30, 2024

 
 

Specialty

Health Care

 

Engineering

 

Life Sciences,

Data and

Solutions

 

Consolidated

 
                 

Revenue

$38,182

 

$23,505

 

$10,252

 

$71,939

 

Cost of services

27,108

 

18,003

 

6,461

 

51,572

 

Gross profit

$11,074

 

$5,502

 

$3,791

 

$20,367

 

Gross profit margin

29.0

%

23.4

%

37.0

%

28.3

%

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In Thousands, Except Share Amounts)

 

 

March 29,

 

December 28,

 
 

2025

 

2024

 
 

(Unaudited)

     

Current assets:

       
 

Cash and cash equivalents

$5,181

 

$4,729

 
 

Accounts receivable, net of provision for credit losses of $1,570

 at March 29, 2025 and December 28, 2024

68,390

 

77,960

 
 

Transit accounts receivable

7,165

 

7,315

 
 

Prepaid expenses and other current assets

5,240

 

7,034

 
   

Total current assets

85,976

 

97,038

 
             

Property and equipment, net

7,371

 

7,368

 
         

Other assets:

       
 

Deposits

233

 

230

 
 

Deferred tax assets, foreign

125

 

120

 
 

Goodwill

22,147

 

22,147

 
 

Operating right of use asset

5,140

 

5,174

 
   

Total other assets

27,645

 

27,671

 
             
   

Total assets

$120,992

 

$132,077

 

 

Current liabilities:

       
 

Accounts payable and accrued expenses

$14,509

 

$13,369

 
 

Transit accounts payable

19,327

 

23,870

 
 

Accrued payroll and related costs

12,581

 

9,929

 
 

Finance lease payable

706

 

698

 
 

Income taxes payable

273

 

346

 
 

Operating right of use liability

1,107

 

1,046

 
 

Contingent consideration from acquisitions

212

 

212

 
 

Deferred revenue

4,519

 

4,163

 
   

Total current liabilities

53,234

 

53,633

 
         

Deferred income taxes, net, domestic

4,526

 

4,526

 

Finance lease payable, net of current position

932

 

1,112

 

Operating right of use liability, net of current position

4,286

 

4,355

 

Borrowings under line of credit

23,414

 

34,967

 
 

Total liabilities

86,392

 

98,593

 
         

Contingencies (note 15)

       
         

Stockholders’ equity:

       
 

Preferred stock, $1.00 par value; 5,000,000 shares authorized;

       
   

no shares issued or outstanding

-

 

-

 
 

Common stock, $0.05 par value; 40,000,000 shares authorized;

       
   

17,928,284 shares issued and 7,508,593 shares outstanding at

March 29, 2025 and 17,838,372 shares issued and 7,602,113 shares

outstanding at December 28, 2024

895

 

890

 
 

Additional paid-in capital

118,956

 

118,845

 
 

Accumulated other comprehensive loss

(2,918

)

(2,920

)

 

Accumulated deficit

(1,752

)

(5,938

)

 

Treasury stock, 10,419,691 shares at March 29, 2025 and

       
   

10,236,259 shares at December 28, 2024

(80,581

)

(77,393

)

   

Total stockholders’ equity

34,600

 

33,484

 
             
   

Total liabilities and stockholders’ equity

$120,992

 

$132,077

 

 

 

 

RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

 

 

 

Thirteen Weeks Ended

 
 

March 29,

2025

 

March 30,

2024

 

Net income

$4,186

 

$3,952

 

Adjustments to reconcile net income to cash

 used in operating activities

1,459

 

1,250

 

Changes in operating assets and liabilities:

       
 

Accounts receivable

9,558

 

(2,802

)

 

Prepaid expenses and other current assets

1,787

 

120

 
 

Net of transit accounts receivable and payable

(4,393

)

(219

)

 

Accounts payable and accrued expenses

1,358

 

1,345

 
 

Accrued payroll and related costs

2,665

 

976

 
 

Right of use liabilities

(241

)

(304

)

 

Income taxes payable

(71

)

451

 
 

Deferred revenue

356

 

1,633

 
 

Deposits

(4

)

24

 

Total adjustments

12,474

 

2,474

 

Net cash provided by operating activities

$16,660

 

$6,426

 
         

Net cash used in investing activities

(427)

 

(669

)

Net cash used in financing activities

(15,583

)

(9,714

)

Effect of exchange rate changes on cash and cash equivalents

(198

)

(228

)

Increase (decrease) in cash and cash equivalents

$452

 

($4,185

)

         

Common stock repurchase

($3,188

)

$     -

 

Retirement of common shares

($939)

 

($1,317

)